OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Hypertension is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension	830
2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement	415
European Society of Hypertension position paper on renal denervation 2021	99
Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the	92
Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability	83
Coronavirus disease 2019 and cardiovascular complications: focused clinical review	66
Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper ∗	58
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study	52
Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic	50
Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension	48
Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension	46
Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019	44
Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial	41
Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during COVID-19: beyond confounding	41
Preeclampsia and severe acute respiratory syndrome coronavirus 2 infection: a systematic review	40
Low-blood pressure phenotype underpins the tendency to reflex syncope	37
Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Socie	36
Trends in hypertension prevalence, awareness, treatment and control rates among Chinese adults, 1991–2015	36
Therapeutic inertia in the management of hypertension in primary care	34
Routine assessment of cognitive function in older patients with hypertension seen by primary care physicians: why and how—a decision-making support from the working group on ‘hypertension and the brai	34
Renin–angiotensin-system inhibitors and all-cause mortality in patients with COVID-19: a systematic review and meta-analysis of observational studies	33
Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign	33
Association between oral health and cardiovascular outcomes in patients with hypertension: a nationwide cohort study	32
Arterial stiffness precedes hypertension and metabolic risks in youth: a review	31
Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes	30

Isolated systolic and diastolic hypertension by the 2017 American College of Cardiology/American Heart Association guidelines and risk of cardiovascular disease: a large prospective cohort study	29
European Society of Hypertension recommendations for the validation of cuffless blood pressure measuring devices: European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardio	28
Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values	27